CASI - CASI Pharmaceuticals GAAP EPS of -$0.77 revenue of $9.82M
2023-08-11 07:45:03 ET
- CASI Pharmaceuticals press release ( NASDAQ: CASI ): Q2 GAAP EPS of -$0.77.
- Revenue of $9.82M (+14.6% Y/Y).
- As of June 30, 2023, CASI had cash, cash equivalents and short-term investments of $36.8 million.
For further details see:
CASI Pharmaceuticals GAAP EPS of -$0.77, revenue of $9.82M